TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has shared an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. has announced the composition of its board of directors and their roles within the company. The announcement outlines the members of the board, including executive, non-executive, and independent non-executive directors, and details their participation in various board committees. This update is significant for stakeholders as it provides insights into the company’s governance structure and strategic direction.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in China, focusing on the medical technology industry. It is involved in developing and commercializing robotic systems for medical applications.
Average Trading Volume: 8,265,484
Technical Sentiment Signal: Buy
Current Market Cap: HK$16.3B
See more data about 2252 stock on TipRanks’ Stock Analysis page.